News | SNMMI | June 27, 2023

During its 2023 Annual Meeting, held June 24-27 in Chicago, the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI named Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford (CA), and clinical professor of radiology at the Stanford School of Medicine, as its President, introduced its new slate of officers and recognized 10 new fellows.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford (CA), and clinical professor of radiology at the Stanford School of Medicine, as its president during its 2023 Annual Meeting, held June 24-27 in Chicago, IL. Image courtesy: Stanford University


June 27, 2023 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The Society introduced a new slate of officers, and recognized new Fellows, during its SNMMI 2023 Annual Meeting, held June 24-27 in Chicago, IL.

Other SNMMI officers elected for 2023-24 include: President-Elect Cathy Sue Cutler, PhD, FSNMMI, Director of the Medical Isotope Research and Production Program (MIRP) at Brookhaven National Laboratory in Upton, New York; and Vice President-Elect Jean-Luc C. Urbain, MD, PhD, FASNC, professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo, Buffalo, New York.

President’s Priorities

Nadel’s goals for her presidential year, as noted in an SNMMI announcement on the appointment, include raising awareness of and access to nuclear medicine, molecular imaging and theranostics to facilitate precision health for all patients.

“The potential impact of nuclear medicine in the care of patients dealing with cancer, heart disease, brain disease, and other challenges is enormous,” she said. “We need to focus on the future of our field and ask important questions, such as ‘What can we do to fast-track the development and approval of diagnostic and theranostic molecular imaging agents?’ and ‘How can we ensure diversity in all parts of the nuclear medicine family?’ to ensure that this impact is realized.”

Other areas of focus include standardization at the global level for the many cutting-edge areas within the field, supporting access with adequate reimbursement and increasing the number of qualified professionals entering the field.

Nadel earned her medical degree from the University of Manitoba in Winnipeg, Manitoba, Canada, in 1977. She completed a diagnostic radiology residency in 1982 at the University of Toronto, followed by a fellowship in pediatric radiology at the Hospital for Sick Children at the University of Toronto, both in Toronto, Ontario, Canada. She then completed a nuclear medicine residency in 1989 at the University of British Columbia, in Vancouver, British Columbia, Canada. Nadel held multiple academic appointments at the University of British Columbia between 1983 and 2018 and was head of the division of nuclear medicine and department of radiology at British Columbia Children’s Hospital before taking on her current roles at Stanford.

Nadel has been an active SNMMI member for more than 30 years, serving as president-elect and in the House of Delegates. She also held positions as president of the Pediatric Imaging Council and member of its board of directors, and she has served on the PET Center of Excellence Board of Directors, Scientific Program Committee, Membership Committee and The Journal of Nuclear Medicine Editorial Board, among other posts. She was president of the SNMMI Pacific Northwest Chapter for many years and currently plays an active role in the Northern California chapter.

In the greater nuclear medicine community, Nadel has served in multiple positions for the American College of Nuclear Medicine, the American Board of Nuclear Medicine, the Radiological Society of North America, the Society for Pediatric Radiology and the Children’s Oncology Group. In 2019, Nadel received the Lifetime Achievement Award from the European Society of Pediatric Nuclear Medicine for ongoing contributions to pediatric nuclear medicine. She has published 76 peer-reviewed journal articles and 24 book chapters and has been an invited speaker for 180 presentations.

Fellows Recognized

Ten new SNMMI Fellows were recognized during a June 25 plenary session at the society’s 2023 Annual Meeting. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members.

In keeping with tradition, reported the Society in a press release issued during the meeting, SNMMI’s 2022-23 president, Munir Ghesani, MD, FACNM, FACR, Mount Sinai Hospital, New York, New York, was honored as an SNMMI Fellow following his term. Also recognized were:

Ramsey Badawi, PhD, University of California Davis Health, Sacramento, California

Erin Grady, MD, CCD, FACNM, Stanford University Medical Center, Stanford, California

John Hoffman, MD, University of Utah School of Medicine, Salt Lake City, Utah

Andrei Iagaru, MD, Stanford University Medical Center, Stanford, California

Martin Pomper, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, Maryland

Arman Rahmim, PhD, University of British Columbia, Vancouver, British Columbia, Canada

Barry Shulkin, MD, St. Jude Children’s Research Hospital, Memphis, Tennessee

Gary Ulaner, MD, PhD, FACNM, Hoag Family Cancer Institute, Irvine, California

In addition, Virginia Pappas, CAE, SNMMI CEO, will be recognized as an honorary Fellow for her many years of service to the society. Selection of SNMMI Fellows is based on documented excellence of volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation, educational efforts in nuclear medicine and molecular imaging, or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship is recognized with the designation FSNMMI.

For more information: www.snmmi.org

Keep up with ITN's coverage of the 2023 SNMMI Annual Meeting news here.


Related Content

News | Computed Tomography (CT)

July 15, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 15, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Feature | SCCT | by Christine Book

June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual ...

Time June 27, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | SIIM

June 20, 2024 — The Society for Imaging Informatics in Medicine (SIIM) is gearing up for its SIIM24 Annual Meeting and ...

Time June 20, 2024
arrow
News | Ultrasound Women's Health

June 18, 2024 — The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) has announced details of ...

Time June 18, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
Subscribe Now